Case study and clinical pharmacists participated pharmaceutical care in glucocorticoids treatment for a patient with liver failure

FAN Mengyao; SONG Lin; TIAN Jing

doi:10.3969/j.issn.1006-0111.2018.05.019

Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name

E-mail

Phone

Title

Content

Verification Code

Objective To explore how clinical pharmacists participating in medication regimen design and carrying out pharmaceutical care. Methods The clinical pharmacist participated in the therapy for a patient with acute-to-chronic liver failure associated with hepatitis B and adjusted the glucocorticoid administration time and dosage based on the mechanism of glucocorticoid action. Results Physicians accepted clinical pharmacist's suggestion and the patient recovered well after the treatment. Conclusion The clinical pharmacist's participation in the treatment and the optimization of medication regimen improved the safety and efficacy of drug treatment.

Case study and clinical pharmacists participated pharmaceutical care in glucocorticoids treatment for a patient with liver failure

1. Department of Pharmacy, Changhai Hospital Affiliated to Second Military Medical University, Shanghai 200433, China;Department of Pharmacy, Wuxi Second Hospital Affiliated to Nanjing Medical University, Wuxi 214002, China

2. Department of ENT, Naval Authority Clinic, Beijing 100841, China

3. Department of Pharmacy, Changhai Hospital Affiliated to Second Military Medical University, Shanghai 200433, China

Received Date: 2018-01-30

Rev Recd Date: 2018-04-13

Key words:

Abstract: Objective To explore how clinical pharmacists participating in medication regimen design and carrying out pharmaceutical care. Methods The clinical pharmacist participated in the therapy for a patient with acute-to-chronic liver failure associated with hepatitis B and adjusted the glucocorticoid administration time and dosage based on the mechanism of glucocorticoid action. Results Physicians accepted clinical pharmacist's suggestion and the patient recovered well after the treatment. Conclusion The clinical pharmacist's participation in the treatment and the optimization of medication regimen improved the safety and efficacy of drug treatment.

HTML

Reference (10)

[1]	张辉艳,张绪清. 糖皮质激素阻止肝衰竭发生与发展的机制[J]. 胃肠病学和肝病学杂志,2016,25(5):481-484.
[2]	张欣. 糖皮质激素治疗肝衰竭疗效及安全性的Meta分析[J]. 实用肝脏病杂志, 2017, 20(1):73-77.
[3]	中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2012年版)[J]. 中华临床感染病杂志,2012,5(6):321-327.
[4]	黄燕,罗二平,黄小平,等. 糖皮质激素对乙型肝炎重症化阻断作用的临床观察[J]. 胃肠病学和肝病学杂志,2011,20(3):272-274.
[5]	周超,罗生强,宫嫚,等. 糖皮质激素在常见肝病治疗中的应用[J]. 胃肠病学和肝病学杂志, 2015, 24(1):15-17.
[6]	ZHANG XQ, JIANG L, YOU JP, et al. Efficacy of short-term dexamethasone therapy in acute-on-chronic pre-liver failure[J]. Hepatol Res, 2011, 41(1):46-53.
[7]	中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会. 自身免疫性肝炎诊断和治疗共识(2015)[J]. 临床肝胆病杂志,2016,32(1):9-22.
[8]	European Association for the Study of the Liver.EASL clinical practice guidelines:autoimmune hepatitis[J]. J Hepatol, 2015, 63(4):971-1004.
[9]	中华医学会肝病学分会脂肪肝和酒精性肝病学组. 酒精性肝病诊疗指南(2010年修订版)[J].中华肝胆病杂志,2010,26,(3):229-232.
[10]	European Association for the Study of Liver. EASL clinical practical guidelines:management of alcoholic liver disease[J]. J Hepatol, 2012, 57(2):399-420.

Message Board

Case study and clinical pharmacists participated pharmaceutical care in glucocorticoids treatment for a patient with liver failure

doi: 10.3969/j.issn.1006-0111.2018.05.019

Abstract

References

Proportional views

通讯作者: 陈斌, [email protected]

Article Metrics

Related

Proportional views